Transfection Technologies Market: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2028

Report DescriptionAbout IMARC Group

The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Global Transfection Technologies Market Research Report:

The latest report by IMARC, titled “ TransfectionTechnologiesMarket:GlobalIndustryTrends,Share,Size,Growth,OpportunityandFore cast2023-2028

” " the global transfection technologies market reached a value of US$ 1,080.2 Million in 2022.

Transfection is a process involving the introduction of foreign nucleic acids, such as Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA) and oligonucleotides, into the eukaryotic cells by nonviral methods.

It is done by using various physical, chemical and biological methods to modify certain properties of the cell.

It is widely used for genomic studies, including cell representation, RNA interference and in vitro research. Apart from this, it can also be employed for the bio-production of vaccines and proteins. The utilization of innovative transfection technologies has led to their increasing applications in drug discovery, target validation and cellular research.

Request Free Sample Report: https://www.imarcgroup.com/transfection-technologies-market/requestsample

Global Transfection Technologies Market Trends:

The market is primarily driven by the increasing incidences of cancer and various lifestyle disorders. The process of transfection is widely used for the development of stem cell and gene-based therapies, which are widely used for the treatment of numerous medical ailments. Apart from this, reagent-based transfection methods are gaining widespread prominence across the globe as they are not only affordable but are also easier to administer in the patient’s body. This, along with the increasing research and development (R&D) in the field of cell-based therapies, is providing a thrust to the market growth. The market is further driven by the incorporation of advanced methods with transfection technologies. This has enabled researchers to analyze the function of a particular gene or gene product by enhancing or inhibiting its expression.

Moreover, these improvements have enabled them to study the function of multiple genes simultaneously within a cell, as well as to upscale the production of recombinant proteins. There have also been significant advancements in recombinant technology and proteomics, which is further creating a positive outlook for the market. Some of the other factors contributing to the market growth include the development of novel techniques used for transient transfection with improved stability and minimal off-target effects, along with the increasing investments by both the private and government organizations to develop large scale transfection facilities. On account of the aforementioned factors, the market is anticipated to grow at a CAGR of 8.5% during 2023-2028.

Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).

Report Description Report Description and Highlights

MarketSummary:

BreakupbyProductType:

• Reagent

• Instrument

• Others

BreakupbyApplication:

• Therapeutic Delivery

• Bio-Medical Research

• Protein Production

• Others

BreakupbyTransfectionMethod:

• Lipofection

• Eletroporation

• Nucleofection

• Cotransfection

• Cationic Lipid Transfection

• In-Vivo Transfection

• Others

BreakupbyTechnology:

• Physical Transfection

• Biochemical Based Transfection

• Viral-Vector Based Transfection

BreakupbyEnd-User:

• Research Centers and Academic Institutes

• Hospitals and Clinics

• Pharmaceutical and Biotechnology Companies

• Others

BreakupbyRegion:

• North America

• United States

• Canada

• Asia Pacific

• China

• Japan

• India

• South Korea

• Australia

• Indonesia

• Others

• Europe

• Germany

• France

• United Kingdom

• Italy

• Spain

• Russia

• Others

• Latin America

• Brazil

• Mexico

• Others

• Middle East and Africa

Report Description Report Description and Highlights

CompetitiveLandscapewithKeyPlayers:

• Agilent Technologies Inc

• Bio-RAD Laboratories Inc.

• Lonza Group AG

• Maxcyte Inc.

• Mirus Bio LLC

• Polyplus Transfection

• Promega Corporation

• Roche Holding AG

• Sigma-Aldrich Corporation

• Thermo Fisher Scientific Inc.

ViewFullReportwithTOC&ListofFigure:

https://www.imarcgroup.com/transfection-technologies-market

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

Report Description Report Description and Highlights

© 2019 IMARC All Rights Reserved

This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.